https://sven-borchmann.owlstown.net https://sven-borchmann.owlstown.net/publications https://sven-borchmann.owlstown.net/projects https://sven-borchmann.owlstown.net/people https://sven-borchmann.owlstown.net/courses https://sven-borchmann.owlstown.net/posts https://sven-borchmann.owlstown.net/pages https://sven-borchmann.owlstown.net/cv https://sven-borchmann.owlstown.net/contact_form https://sven-borchmann.owlstown.net/publications/36165-noninvasive-minimal-residual-disease-assessment-in-relapsed-refractory-large-b-cell-lymphoma-using-digital-droplet-pcr https://sven-borchmann.owlstown.net/publications/36167-human-leukocyte-antigen-hla-class-i-expression-on-hodgkin-reed-sternberg-cells-is-an-ebv-independent-major-determinant-of-microenvironment-composition-in-classic-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/36166-multicenter-development-of-a-pet-based-risk-assessment-tool-for-product-specific-outcome-prediction-in-large-b-cell-lymphoma-patients-undergoing-car-t-cell-therapy https://sven-borchmann.owlstown.net/publications/36164-specialized-palliative-care-in-patients-with-haematological-malignancies-receiving-chimeric-antigen-receptor-t-cell-therapy https://sven-borchmann.owlstown.net/publications/27170-entirely-noninvasive-outcome-prediction-in-central-nervous-system-lymphomas-using-circulating-tumor-dna https://sven-borchmann.owlstown.net/publications/38004-circulating-tumor-dna-sequencing-for-biologic-classification-and-individualized-risk-stratification-in-patients-with-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/19103-outcome-prediction-in-patients-with-large-b-cell-lymphoma-undergoing-chimeric-antigen-receptor-t-cell-therapy https://sven-borchmann.owlstown.net/publications/24014-clinical-applications-of-circulating-tumor-dna-in-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/19104-potential-synergy-between-radiotherapy-and-car-t-cells-a-multicentric-analysis-of-the-role-of-radiotherapy-in-the-combination-of-car-t-cell-therapy https://sven-borchmann.owlstown.net/publications/16561-blood-based-monitoring-of-relapsed-refractory-hodgkin-lymphoma-patients-predict-responses-to-anti-pd-1-treatment https://sven-borchmann.owlstown.net/publications/16404-coming-of-age-the-evolving-role-of-circulating-tumor-dna-in-malignant-lymphoma https://sven-borchmann.owlstown.net/publications/16559-controversies-in-the-interpretation-of-liquid-biopsy-data-in-lymphoma https://sven-borchmann.owlstown.net/publications/16560-tripartite-antigen-agnostic-combination-immunotherapy-cures-established-poorly-immunogenic-tumors https://sven-borchmann.owlstown.net/publications/2234-an-atlas-of-the-tissue-and-blood-metagenome-in-cancer-reveals-novel-links-between-bacteria-viruses-and-cancer https://sven-borchmann.owlstown.net/publications/2226-tumor-and-microenvironment-response-but-no-cytotoxic-t-cell-activation-in-classic-hodgkin-lymphoma-treated-with-anti-pd1 https://sven-borchmann.owlstown.net/publications/2832-throly-score-successfully-classifies-hodgkin-lymphoma-patients-at-risk-of-thromboembolic-complication https://sven-borchmann.owlstown.net/publications/2209-liquid-biopsy-in-lymphoma-molecular-methods-and-clinical-applications https://sven-borchmann.owlstown.net/publications/2216-steering-chimeric-antigen-receptor-t-cells-into-the-hodgkin-lymphoma-niche https://sven-borchmann.owlstown.net/publications/2215-clearance-of-jc-polyomavirus-from-cerebrospinal-fluid-following-treatment-with-interleukin-2-and-pembrolizumab-in-an-individual-with-progressive-multifocal-leukoencephalopathy-and-no-underlying-immune-deficiency-syndrome https://sven-borchmann.owlstown.net/publications/2203-inhibition-of-tumor-vegfr2-induces-serine-897-epha2-dependent-tumor-cell-invasion-and-metastasis-in-nsclc https://sven-borchmann.owlstown.net/publications/2224-an-update-on-disease-biomarkers-for-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2232-programmed-cell-death-protein1-pd1-expression-in-the-microenvironment-of-classical-hodgkin-lymphoma-at-relapse-after-conventional-chemotherapy-and-at-relapse-on-anti-pd1-treatment https://sven-borchmann.owlstown.net/publications/2214-pretreatment-vitamin-d-deficiency-is-associated-with-impaired-progression-free-and-overall-survival-in-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2225-nivolumab-in-relapsed-refractory-classical-hodgkin-lymphoma-extended-follow-up-of-30-patients-treated-within-the-checkmate-205-trial-in-a-single-center https://sven-borchmann.owlstown.net/publications/2218-thrombosis-as-a-treatment-complication-in-hodgkin-lymphoma-patients-a-comprehensive-analysis-of-three-prospective-randomized-german-hodgkin-study-group-ghsg-trials https://sven-borchmann.owlstown.net/publications/2222-the-khorana-score-for-prediction-of-venous-thromboembolism-in-cancer-patients-a-systematic-review-and-meta-analysis https://sven-borchmann.owlstown.net/publications/2206-active-surveillance-for-nodular-lymphocyte-predominant-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2205-suicide-in-european-hodgkin-lymphoma-patients https://sven-borchmann.owlstown.net/publications/2220-symptomatic-osteonecrosis-as-a-treatment-complication-in-hodgkin-lymphoma-an-analysis-of-the-german-hodgkin-study-group-ghsg https://sven-borchmann.owlstown.net/publications/2219-the-translational-science-of-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2212-programmed-cell-death-protein-1-pd-1-expression-in-the-microenvironment-of-classical-hodgkin-lymphoma-at-relapse-during-anti-pd-1-treatment https://sven-borchmann.owlstown.net/publications/2233-examining-rare-side-effects-in-pooled-trial-data-symptomatic-osteonecrosis-in-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2231-hodgkin-lymphoma-in-elderly-patients https://sven-borchmann.owlstown.net/publications/2208-combined-vegf-and-pd-l1-blockade-displays-synergistic-treatment-effects-in-an-autochthonous-mouse-model-of-small-cell-lung-cancer https://sven-borchmann.owlstown.net/publications/2213-synergistic-anti-angiogenic-treatment-effects-by-dual-fgfr1-and-vegfr1-inhibition-in-fgfr1-amplified-breast-cancer https://sven-borchmann.owlstown.net/publications/2217-leucocyte-and-eosinophil-counts-predict-progression-free-survival-in-relapsed-or-refractory-classical-hodgkin-lymphoma-patients-treated-with-pd1-inhibition https://sven-borchmann.owlstown.net/publications/2229-the-genetics-of-hodgkin-lymphoma-an-overview-and-clinical-implications https://sven-borchmann.owlstown.net/publications/2230-hodgkin-lymphoma-has-a-seasonal-pattern-of-incidence-and-mortality-that-depends-on-latitude https://sven-borchmann.owlstown.net/publications/2228-novel-agents-in-classical-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2204-long-term-follow-up-of-contemporary-treatment-in-early-stage-hodgkin-lymphoma-updated-analyses-of-the-german-hodgkin-study-group-hd7-hd8-hd10-and-hd11-trials https://sven-borchmann.owlstown.net/publications/2221-current-developments-in-the-treatment-of-early-stage-classical-hodgkin-lymphoma https://sven-borchmann.owlstown.net/publications/2202-bleomycin-in-older-early-stage-favorable-hodgkin-lymphoma-patients-analysis-of-the-german-hodgkin-study-group-ghsg-hd10-and-hd13-trials https://sven-borchmann.owlstown.net/publications/2227-multi-specific-antibodies-for-cancer-immunotherapy https://sven-borchmann.owlstown.net/publications/2210-the-bispecific-immunoligand-ulbp2-acea-redirects-natural-killer-cells-to-tumor-cells-and-reveals-potent-anti-tumor-activity-against-colon-carcinoma https://sven-borchmann.owlstown.net/projects/272-liquid-biopsies https://sven-borchmann.owlstown.net/projects/277-translational-research-in-hodgkin-lymphoma https://sven-borchmann.owlstown.net/projects/278-cancer-microbiome https://sven-borchmann.owlstown.net/projects/279-bispecific-antibody-development https://sven-borchmann.owlstown.net/projects/280-drug-repurposing-for-immunotherapy https://sven-borchmann.owlstown.net/people/2012-iris-buchberger-bachelor-student https://sven-borchmann.owlstown.net/people/192-sven-borchmann-md https://sven-borchmann.owlstown.net/people/4037-johann-siebenaller https://sven-borchmann.owlstown.net/people/2009-verena-kern-master-student https://sven-borchmann.owlstown.net/people/197-niels-kothemann-md-student https://sven-borchmann.owlstown.net/people/348-jan-michel-heger-md https://sven-borchmann.owlstown.net/people/2008-jomy-kuruvila-master-student https://sven-borchmann.owlstown.net/people/2005-julia-schleifenbaum-md https://sven-borchmann.owlstown.net/people/343-mia-lohmann-md https://sven-borchmann.owlstown.net/people/341-max-freihammer https://sven-borchmann.owlstown.net/people/1651-jessica-schneider https://sven-borchmann.owlstown.net/people/195-laman-mammadova-md https://sven-borchmann.owlstown.net/people/342-anne-catherine-neumann-md https://sven-borchmann.owlstown.net/people/1652-yang-yu https://sven-borchmann.owlstown.net/people/196-julia-mattlener https://sven-borchmann.owlstown.net/people/2006-jennifer-schitz-md-student https://sven-borchmann.owlstown.net/people/1650-paul-reichelt https://sven-borchmann.owlstown.net/people/2007-meike-schwandt-bachelor-student https://sven-borchmann.owlstown.net/people/2011-sophia-sobesky-md-student https://sven-borchmann.owlstown.net/people/3439-sophie-heidenreich https://sven-borchmann.owlstown.net/people/198-andrea-steliou-md-student https://sven-borchmann.owlstown.net/people/2010-zhiyuan-shi-postdoc https://sven-borchmann.owlstown.net/people/199-pramudini-jayalath https://sven-borchmann.owlstown.net/people/194-olivia-kasgen https://sven-borchmann.owlstown.net/pages/416-untitled-bmndmm https://sven-borchmann.owlstown.net/pages/282-untitled https://sven-borchmann.owlstown.net/pages/387-untitled-wtzgvb